Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas
- 30 April 2007
- journal article
- Published by Elsevier BV in Surgery
- Vol. 141 (4), 520-529
- https://doi.org/10.1016/j.surg.2006.10.010
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A Novel Approach to Cancer Therapy Using an Oncolytic Herpes Virus to Package Amplicons Containing Cytokine GenesMolecular Therapy, 2001
- Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancerJournal of the American College of Surgeons, 2001
- Cytokine Gene Transfer Enhances Herpes Oncolytic Therapy in Murine Squamous Cell CarcinomaHuman Gene Therapy, 2001
- Effects of Preexisting Immunity on the Response to Herpes Simplex-Based Oncolytic Viral TherapyHuman Gene Therapy, 2000
- Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancerCancer Gene Therapy, 2000
- Selective Infection and Cytolysis of Human Head and Neck Squamous Cell Carcinoma with Sparing of Normal Mucosa by a Cytotoxic Herpes Simplex Virus Type 1 (G207)Human Gene Therapy, 1999
- Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsGene Therapy, 1998
- Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisalBritish Journal of Surgery, 1995
- Dormant liver metastases: an experimental studyBritish Journal of Surgery, 1992
- In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in RodentsThe Journal of Infectious Diseases, 1988